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The cellular prion protein PrPC, encoded by 
the Prnp gene, is tethered to the membrane of 
most mammalian cells by a glycosylphosphati-
dylinositol anchor. Conversion and aggregation 
of PrPC into a misfolded conformer (termed 
PrPSc) triggers transmissible spongiform encepha-
lopathies, also termed prion diseases (Aguzzi 
and Calella, 2009). Disparate functions have 
been ascribed to PrPC on the basis of pheno-
types described in Prnp/ mice (Steele et al., 
2007; Linden et al., 2008), yet none of these 
functions has been clarified mechanistically, and 
their validity was frequently challenged.
All currently available Prnp/ lines were gen-
erated using embryonic stem (ES) cells derived 
from the 129 strain of Mus musculus. Typically, 
chimeric founder mice were crossed with WT 
(Prnpwt/wt) mice of the C57BL/6 strain (B6; Table 1). 
The resulting mice carrying the targeted allele 
were maintained as a mixed B6/129 back-
ground (B6129) or backcrossed to inbred strains 
(mainly B6), often for >10 generations, to gen-
erate congenic B6.129 mice (the period in B6.129 
denotes congenesis, as opposed to mixed B6129 
mice). Although the latter approach progres-
sively reduces the contribution of the 129-
derived genome, Prnp-linked genomic intervals 
may co-segregate with Prnp (Sparkes et al., 1986). 
Consequently, congenic Prnpwt/wt and Prnp/ 
mice may differ at additional polymorphic loci 
(Smithies and Maeda, 1995; Gerlai, 1996). We 
hypothesized that co-segregation of linked 
genes may have confounded the attribution 
of functions to PrPC based on phenotypes ob-
served in Prnp/ mice (Collinge et al., 1994; 
Lledo et al., 1996; Walz et al., 1999; Rangel et al., 
2007; Laurén et al., 2009; Calella et al., 2010; 
Gimbel et al., 2010; Ratté et al., 2011; Striebel 
et al., 2013).
Here we selected a cell-autonomous pheno-
type previously reported in congenic B6.129-
PrnpZrchI/ZrchI mice (Büeler et al., 1992): inhibition 
of phagocytosis of apoptotic cells (de Almeida 
et al., 2005). We used RNA sequencing to identify 
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Prnp/ mice lack the prion protein PrPC and are resistant to prion infections, but variable 
phenotypes have been reported in Prnp/ mice and the physiological function of PrPC remains 
poorly understood. Here we examined a cell-autonomous phenotype, inhibition of macrophage 
phagocytosis of apoptotic cells, previously reported in Prnp/ mice. Using formal genetic, 
genomic, and immunological analyses, we found that the regulation of phagocytosis previously 
ascribed to PrPC is instead controlled by a linked locus encoding the signal regulatory protein  
(Sirpa). These findings indicate that control of phagocytosis was previously misattributed to the 
prion protein and illustrate the requirement for stringent approaches to eliminate confounding 
effects of flanking genes in studies modeling human disease in gene-targeted mice. The pleth-
ora of seemingly unrelated functions attributed to PrPC suggests that additional phenotypes 
reported in Prnp/ mice may actually relate to Sirpa or other genetic confounders.
© 2013 Nuvolone et al. This article is distributed under the terms of an Attribution– 
Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.rupress.org/terms). After six months 
it is available under a Creative Commons License (Attribution–Noncommercial–
Share Alike 3.0 Unported license, as described at http://creativecommons.org/ 
licenses/by-nc-sa/3.0/).
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Theocharides et al., 2012; Yamauchi et al., 2013). Binding of 
CD47 on cognate cells to SIRP on macrophages transmits a 
“don’t eat me” signal that protects the targets from phagocy-
tosis (Matozaki et al., 2009; Chao et al., 2012). Down-regulation 
of CD47 cell surface expression on ageing or apoptotic cells en-
hances their phagocytosis (Barclay and Brown, 2006; Matozaki 
et al., 2009). Polymorphisms of the Ig-like amino-terminal 
domain of SIRP can affect CD47 binding and modulate 
phagocytosis (Takenaka et al., 2007; Legrand et al., 2011; 
Strowig et al., 2011; Theocharides et al., 2012). These charac-
teristics led us to prioritize Sirpa as the most plausible candi-
date for modifying the phagocytic phenotype described in 
B6.129-PrnpZrchI/ZrchI versus B6.129-Prnpwt/wt mice.
Sirpa9 segregates with Prnp in seven Prnp/ lines
We then analyzed Sirpa alleles in PrnpZrchI/ZrchI mice and in six 
additional, independently generated mouse lines carrying tar-
geted Prnp deletions (Table 1, Fig. 2, and Fig. S1). Restriction 
fragment length polymorphism (RFLP) analysis and DNA 
sequencing revealed that the targeted Prnp allele co-segregated 
with the Sirpa allele of the 129 strain (Sirpa129) in PrnpZrchI/ZrchI 
mice that had been backcrossed >17 generations to BALB/c 
(C) or for >12 generations to B6 mice in our colony (Fig. 2). 
We also observed co-segregation of Prnp and Sirpa alleles in 
PrnpZrchI/ZrchI mice backcrossed for 12 generations to B6 and in 
PrnpEdbg/Edbg backcrossed for ≤18 generations to B6 mice from 
four different laboratories (Figs. S1 and S2 and not depicted). 
Similar results were observed for alleles at Mertk, Tyro3, and 
Thbs1, with the exception of an independently generated 
congenic Prnp/ line called “Ngsk” (Table 1 and Table S3). 
Congenic B6.129-PrnpNgsk/Ngsk mice have the genotypes 
Sirpa129/129 Mertk129/129 Tyro3B6/B6 Thbs1B6/B6, likely reflecting 
a recombination event during repeated backcrossing to B6 
mice. Thus, Sirpa and/or another of the three genes could af-
fect the hyperphagocytosis phenotype reported in PrnpZrchI/ZrchI 
mice (de Almeida et al., 2005).
Functional analysis excludes Prnp and points to Sirpa  
as the gene controlling phagocytosis
We then sought to determine the contribution of polymor-
phic Prnp-flanking genes to the phagocytic phenotype of 
genes linked to Prnp and expressed in macrophages that may 
influence this phenotype. We report genetic and functional evi-
dence that the regulation of phagocytosis previously ascribed 
to Prnp/ is instead controlled by the closely linked gene signal 
regulatory protein  (Sirpa; Matozaki et al., 2009).
RESULTS
RNA sequencing indicates Sirpa as a candidate  
modulator of phagocytosis
Because hyperphagocytosis was reported in PrnpZrchI/ZrchI  
mice after extensive backcrossing to B6, we reasoned that any 
genetic confounders leading to this phenotype in B6.129- 
PrnpZrchI/ZrchI mice would need to be physically linked to Prnp, 
polymorphic between 129 and B6 strains, and expressed in 
macrophages. To identify such genes, we performed RNA se-
quencing on B6.129-PrnpZrchI/ZrchI and B6.129-Prnpwt/wt peri-
toneal macrophages (pMs). Of 11,586 genes, 305 were 
differentially expressed between the two groups (Fig. 1 A and 
Table S1). We then analyzed the reads for the presence of 
deviations from the B6 reference transcriptome (Fig. 1 B and 
Table 2) and applied a step-wise filtering strategy to narrow 
down potential confounding candidate genes (Fig. 1 C). 
B6.129-PrnpZrchI/ZrchI pMs showed significantly more devia-
tions from the B6 reference than did B6.129-Prnpwt/wt (Fig. 1 B 
and Table 2). By plotting the density of sequence variations 
in B6.129-PrnpZrchI/ZrchI pM mRNA against their physical 
location, we observed clustering of variants on chromosome 
2 (Chr 2) around Prnp at 128–156 Mbp (Fig. 1 B).
Of all genes transcribed in pMs, 132 showed nonsynon-
ymous coding variants between B6.129-Prnpwt/wt and B6.129-
PrnpZrchI/ZrchI (Fig. 1 C and Table S2). Of these, 62 mapped to 
Chr 2, 4 of which, Sirpa (Matozaki et al., 2009; Chao et al., 
2012), Mertk (Scott et al., 2001), Tyro3 (Seitz et al., 2007), and 
Thbs1 (Gao et al., 1996), had been previously described to 
impact phagocytosis (Fig. 1 C).
Of these four candidate genes, Sirpa (Fig. 1 C) encodes 
the transmembrane SIRP, is closely linked to Prnp (≈2.2 
Mbp), is highly polymorphic in laboratory mice (Sano et al., 
1999), and, uniquely among the four candidates, displays poly-
morphisms with robust modulatory effects on phagocytosis 
(Takenaka et al., 2007; Legrand et al., 2011; Strowig et al., 2011; 
Table . Prnp KO mouse lines analyzed in this study
Prnp KO mouse line ES cells Origin of ES cells Strain of partner of 
chimeric mouse
Location of colony Reference
PrnpZrchI/ZrchI AB1 129S7/SvEvBrd B6 Zurich, Switzerland Büeler et al. (1992)
PrnpNgsk/Ngsk J1 129S4/SvJae B6 Nagasaki, Japan Sakaguchi et al. (1995)
PrnpEdbg/Edbg E14 129/Ola 129/Ola Edinburgh, Scotland, UK Manson et al. (1994)
PrnpGFP/GFP HM-1 129/Ola B6 Cambridge, MA Heikenwalder et al. (2008)
PrnpRkn/Rkn E14 129P2/OlaHsd B6 Wako-shi, Japan Yokoyama et al. (2001)
PrnpZrchII/ZrchII E14.1 129/OlaHsd B6 Zurich, Switzerland Rossi et al. (2001)
PrnpRcm0/Rcm0 HM-1 129/Ola 129/Ola Edinburgh, Scotland, UK Moore et al. (1995)
The present study is based on the analysis of mice carrying seven independently generated Prnp-null alleles. PrnpEdbg/Edbg and PrnpRcm0/Rcm0 were always crossed to isogenic 
129/Ola mice, whereas all other Prnp/ mice were crossed to B6 mice and then kept on a mixed B6 and 129 background or further backcrossed to B6 or other strains.
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mice (Fig. 3 A, right; Manson et al., 1994) displayed similar 
phagocytic activity as 129-Prnpwt/wt pMs (Fig. 3 B, right). 
129-PrnpEdbg/Edbg were generated from 129 ES cells and main-
tained as a co-isogenic 129 line (Fig. 3 A, right). The two 
strains showed no differences in microsatellite markers linked 
to Prnp (Fig. 3 C). Consequently, ablation of Prnp was insuffi-
cient to drive hyperphagocytosis, suggesting the influence of 
additional genetic elements in Zrchl and Ngsk mice.
To define the 129-derived regions flanking Prnp, we per-
formed microsatellite analyses of Chr 2 in B6.129-Prnp/ 
mice of the ZrchI and Ngsk lines. B6.129-PrnpZrchI/ZrchI mice 
Prnp/ mice. The phagocytic activity of primary macrophages 
was compared between Prnpwt/wt and three different strains of 
Prnp/ mice differing at all four, two, or none of the closely 
linked polymorphic genes. When offered apoptotic thymo-
cytes as targets, B6.129-PrnpZrchI/ZrchI pMs displayed higher 
rates of phagocytosis than those from heterozygous B6.129-
Prnpwt/ZrchI or WT B6.129-Prnpwt/wt congenic littermates (Fig. 3, 
A and B, left) in agreement with a previous study (de Almeida 
et al., 2005). We also observed this hyperphagocytic phenotype 
in BMDMs of B6.129-PrnpZrchI/ZrchI and B6.129-PrnpNgsk/Ngsk 
mice (Fig. 3 B, middle). In contrast, pMs from 129-PrnpEdbg/Edbg 
Figure . RNA sequencing identifies 
macrophage-expressed genes potentially 
controlling phagocytosis in PrnpZrchI/ZrchI 
versus Prnpwt/wt mice. (A) mRNA heat map 
highlighting 305 differentially expressed 
genes between B6.129-PrnpZrchI/ZrchI and 
B6.129-Prnpwt/wt (pMs, three mice per 
group), ordered by chromosomal location 
(vertical) and unsupervised hierarchical 
clustering (horizontal). Chr 2 (in yellow) 
contains significantly more differentially 
expressed genes (P = 0.0011, based on  
Z score > 44 and corrected for chromosome 
size). Individual genes are listed in Table S1. 
(B) Physical distribution of SNPs unique to 
the B6.129-PrnpZrchI/ZrchI pM transcriptome 
clustered on Chr 2 (in yellow; two-tailed 
Student’s t test, P = 0.019) at 128–156 
Mbp. (C) Filtering strategy to prioritize 
genes controlling phagocytosis in PrnpZrchI/
ZrchI versus Prnpwt/wt mice. Sequential filters 
were applied to a total of 22,981 SNPs dif-
fering between the B6.129-PrnpZrchI/ZrchI and 
B6.129-Prnpwt/wt pM transcriptomes. SNPs 
affecting protein coding sequence included 
nonsynonymous SNPs and insertions/dele-
tions. The asterisk indicates phenotypic 
definition based on gene ontology annota-
tions and PubMed searches. Sirpa, Mertk, 
Thbs1, and Tyro3 display nonsynonymous 
SNPs between B6.129-PrnpZrchI/ZrchI and 
B6.129-Prnpwt/wt mice, reside on Chr 2, and 
are involved in phagocytosis. However, only 
Sirpa (purple) is known to display polymor-
phisms that modulate phagocytosis.
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We identified only one nonsynonymous single nucleotide 
polymorphism (SNP) in Mertk129 versus MertkB6 alleles (Chr2: 
128776396, Att/Gtt). This SNP, previously reported in CD-1 
mice (SNP accession no. rs27446326 from dbSNP Build 137), 
results in a conservative isoleucine-to-valine substitution within 
the transmembrane region (I516V) and is predicted by the 
SIFT algorithm (Ng and Henikoff, 2001; Kumar et al., 2009) 
to be tolerated and unlikely to impact Mertk function. All dis-
ease-causing MERTK mutations identified so far in patients 
suffering from retinitis pigmentosa (Gal et al., 2000), Leber 
congenital amaurosis (Li et al., 2011), or cancer (Greenman 
et al., 2007) were located in the extracellular or cytoplasmic 
but not in the transmembrane region. Moreover, one natural 
harbored 129-derived genomic material in a region of ≥48 
Mbp flanking Prnp on Chr 2 (including Sirpa, Mertk, Tyro3, 
and Thbs1 alleles) despite >12 generations of backcross to B6 
(Fig. 3 C and Fig. S2).
Compared with B6.129-PrnpZrchI/ZrchI, B6.129-PrnpNgsk/Ngsk 
mice contained a smaller 129-derived interval on Chr 2 
(Fig. 3 C). These mice were homozygous for 129 alleles at 
Sirpa and Mertk and homozygous for B6 alleles at Tyro3 and 
Thbs1 (Fig. 3 C). Because B6.129-PrnpNgsk/Ngsk mice retained 
the hyperphagocytic phenotype, variations in Tyro3 or Thbs1 
alleles did not explain the differential phagocytic activity 
of Prnpwt/wt and Prnp/ mice, excluding these two genes as 
candidates (Fig. 3 C).
Table . Summary statistics of RNA sequencing
Mouse Total reads Mapped reads Mean coverage # SNPs # Het. SNPs # Hom. SNPs # Indels # Nonsyn. 
variants
# Nonsyn. 
variant genes
WT 1 58,838,924 56,801,099 (96.5%) 58.6x 102,465 14,249 88,216 6,860 2,902 362
WT 2 56,971,575 55,447,441 (97.3%) 60.1x 102,756 12,591 90,165 7,451 2,874 361
WT 3 77,632,102 75,325,378 (97.0%) 67.4x 117,354 15,501 101,853 8,356 3,360 415
All WT 84,205 9,535 74,670 5,644 2,277 197
KO 1 71,507,393 69,906,771 (97.8%) 64.6x 117,979 15,146 102,833 8,164 3,517 466
KO 2 70,456,814 68,728,168 (97.5%) 62.7x 114,906 14,943 99,963 8,185 3,391 466
KO 3 75,295,650 73,039,778 (97.0%) 65.4x 117,592 15,539 102,053 8,405 3,515 488
All KO 92,176 9,569 82,607 6,397 2,682 264
WT, B6.129-Prnpwt/wt; KO, B6.129-PrnpZrchI/ZrchI; #, number; Het., heterozygous; Hom., homozygous; Indels, insertions/deletions; Nonsyn., nonsynonymous.
Figure . Sirpa allelotype of the Prnp/ lines 
analyzed in this study. (A) RFLP analysis of Sirpa 
allelotypes. The Sirpa129 allele segregates with the 
Prnp allele in Prnp/ mouse lines stemming from 
seven independent targeting events (see Table 1). The 
8th through 11th lanes show respective reference 
strain DNA. (B) The red box indicates protein se-
quence alignment of mouse SIRP Ig-like variable 
domain (IgV) confirming the 129 Sirpa allelotype in 
each one of the seven Prnp/ lines shown in A. The 
blue box indicates SIRP protein reference sequences 
for the B6, 129/Sv, and 129/Ola strains. Polymor-
phisms are highlighted in yellow. For each group one 
mouse was analyzed.
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Figure . Ablation of Prnp is not sufficient to enhance phagocytosis of apoptotic cells. (A) Generation of B6.129 congenic (left) and 129 
co-isogenic (right) Prnp/ lines. In B6.129 congenic mice, residual 129 genomic material derived from the ES cell (brown) is inevitably present, 
particularly in the region flanking the targeted locus. (B, left) pMs from congenic B6.129-PrnpZrchI/ZrchI mice showed higher phagocytic activity 
than those from B6.129-Prnpwt/wt (set as 100%) and B6.129-Prnpwt/ZrchI littermates. Blue, black, and gray (here and henceforth) indicate data from 
independent experiments. (middle) B6.129-PrnpZrchI/ZrchI and B6.129-PrnpNgsk/Ngsk BMDMs showed higher phagocytic activity than B6-Prnpwt/wt mac-
rophages (set as 100%). (right) The phagocytic activity of 129-PrnpEdbg/Edbg and 129-Prnpwt/wt macrophages was similar, even when two different 
macrophage/thymocyte (M:T) ratios were used (1:10 and 1:1; one-way ANOVA, Bonferroni’s multiple comparisons test). Mean 129-Prnpwt/wt 
phagocytic rate at 1:10 M:T ratio was set as 100%. n.s., not significant; **, P < 0.005; ***, P < 0.001; ****, P < 0.0001. Error bars indicate SD. (C) STR 
analysis of Chr 2. Name and physical position of each STR marker (colored boxes) are indicated on the left. B6.129-PrnpZrchI/ZrchI and B6.129-
PrnpNgsk/NgskI mice contained 129-derived genetic material flanking Prnp, whereas the markers flanking Prnp in 129-PrnpEdbg/Edbg and 129-Prnpwt/wt 
mice were identical. Data show representative mice of at least three animals analyzed per group.
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Figure 4. SirpaB allele segregates with enhanced inhibition of phagocytosis in the absence of Prnp. (A) Breeding scheme applied to generate 
B6129-PrnpZrchI/ZrchI mice containing SirpaB6 and Sirpa129 alleles. B6129-PrnpZrchI/ZrchI SirpaB6/B6 tga20tg/tg mice (F0) were backcrossed to B6129-PrnpZrchI/ZrchI 
Sirpa129/129 mice for two generations to produce B6129-PrnpZrchI/ZrchI littermates, with all combinations of SirpaB6 and Sirpa129 alleles (F3) used to assess 
phagocytic activity as in C. (B) RFLP analysis of Sirpa allelotypes (B6 vs. 129). Surprisingly, tga20 mice (first through third lanes) displayed combinations 
of SirpaB6 and Sirpa129 alleles. The fourth through sixth lanes show B6129-PrnpZrchI/ZrchI mice labeled in A (red arrows). Controls are reference DNA. All 
animals entering the study were analyzed. (C) Phagocytic hyperactivity of B6129-PrnpZrchI/ZrchI pMs was associated with the Sirpa129/129 allelotype. Data 
from three independent experiments (blue, black, and gray) normalized against mean B6129-PrnpZrchI/ZrchISirpaB6/B6 phagocytic rates. One-way ANOVA, 
Bonferroni’s multiple comparisons test: *, P < 0.05; ***, P < 0.001. Error bars indicate SD. (D) STR analysis documenting the boundaries of B6 versus 129-
derived genome in Chr 2 of B6129-PrnpZrchI/ZrchI with different combinations of Sirpa alleles (B6 vs. 129). Name and position of each STR marker (colored 
box) on Chr 2 are indicated on the left. Data show representative mice of at least three animals analyzed per group.
non–disease-causing variant in the transmembrane region has 
been reported in humans (I518V; Gal et al., 2000; Li et al., 
2011), which corresponds to the I516V variant in our mice, 
again suggesting that the variant identified in our mice is un-
likely to impact Mertk function. Collectively, these findings 
suggested that Sirpa129 homozygosity conferred differential levels 
of phagocytosis in otherwise genetically homogeneous mice and 
that the presence of at least one SirpaB6 allele reduced rates of 
phagocytosis compared with Sirpa129 homozygotes.
SirpaB association with inhibition of phagocytosis
We observed that some of our PrPC-overexpressing tga20 
transgenic mice on a mixed B6129-PrnpZrchI/ZrchI background 
(Fischer et al., 1996) were segregating SirpaB6 and Sirpa129  
alleles, likely reflecting an unintentional cross with B6-Prnpwt/wt 
breeders in the early days of this colony (unpublished data). We 
crossed B6129-PrnpZrchI/ZrchI SirpaB6/B6 tga20tg/tg mice to B6129-
PrnpZrchI/ZrchI Sirpa129/129 mice producing B6129-PrnpZrchI/ZrchI 
littermates with all three combinations of SirpaB6 and Sirpa129 
alleles (Fig. 4, A and B). pMs from B6129-PrnpZrchI/ZrchI 
Sirpa129/129 mice showed higher rates of phagocytosis (Fig. 4, 
C and D). Hence, compared with Sirpa129/129, a single SirpaB6 
allele reduced phagocytosis rates in the absence of Prnp. These 
results supported the hypothesis that homozygosity for Sirpa129 
rather than Prnp deficiency was responsible for the hyperpha-
gocytic phenotype of PrnpZrchI/ZrchI mice.
Inhibition of phagocytosis segregated  
with SirpaB in Prnpwt/wt mice
Sirpa alleles and Prnp ablation may impact phagocytosis in-
dependently of each other. We therefore asked whether dif-
ferent Sirpa alleles could modify phagocytosis in Prnpwt/wt 
mice. We genotyped 103 pups from B6.129-Prnpwt/ZrchI SirpaB6/129 
intercross mice for recombination between Prnp and Sirpa and 
observed two events producing a Prnpwt-Sirpa129 and a PrnpZrchI-
SirpaB6 haplotype (Fig. 5 A). Mice carrying the original and the 
recombinant haplotypes were then bred to generate congenic 
mice with different Prnp-Sirpa haplotypes (Fig. 5, B and C).
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not observe differences in Sirpa mRNA levels between pMs 
from B6.129-PrnpZrchI/ZrchI and B6.129-Prnpwt/wt mice (375.60 
vs. 356.34 fragments per kilobase of transcript per million 
The various Prnp-Sirpa haplotypes did not affect the fre-
quency of macrophages in peritoneal lavages, nor did Sirpa 
allelotypes affect PrPC expression (Fig. 6, A–C). Also, we did 
Figure . Hyperphagocytosis is associated with the Sirpa9/9 allelotype but not with Prnp gene dosage. (A) Breeding scheme to generate 
recombinant congenic B6.129 mice with different combinations of Prnp (WT and ZrchI) and Sirpa (B6 and 129) alleles. B6.129-Prnpwt/ZrchI mice (F1) were 
intercrossed, and F2 offspring were screened for meiotic recombination between Prnp and Sirpa. 103 F2 mice with different combinations of Prnp geno-
types and Sirpa allelotypes were obtained. Two mice (red frames) were found to carry the recombinant haplotype, Prnpwt-Sirpa129 and PrnpZrchI-SirpaB6 
and were interbred to generate B6.129-PrnpZrchI/ZrchI and B6.129-Prnpwt/wt mice homozygous for SirpaB6 or Sirpa129 alleles. (B) RFLP analysis to discriminate 
between Sirpa129 and SirpaB6. B6.129-Prnpwt/wt (first, third, and fifth lanes) and B6.129-PrnpZrchI/ZrchI (second, fourth, and sixth lanes) mice with different 
combinations of Sirpa129 and SirpaB6 alleles. Controls are reference DNA. All animals entering the study were analyzed. (C) Protein sequence variants (yel-
low) in SIRP Ig-like variable domain (IgV). Homozygous recombinant congenic B6.129 mice displayed four combinations of Prnp-Sirpa haplotypes (black 
boxes). Blue boxes show SIRP sequence of reference B6 and 129/Sv strains. For each group one mouse was analyzed. (D) Sirpa129/129, but not Prnp/, 
was associated with hyperphagocytosis in pMs from congenic B6.129 mice. Data are from two independent experiments (blue and black); phagocytosis 
rates were normalized against B6.129 Prnpwt/wt SirpaB6/B6. One-way ANOVA, Bonferroni’s multiple comparisons post-test: *, P < 0.05; ****, P < 0.0001. Error 
bars indicate SD. (E) Recombination breakpoints between Prnp and Sirpa in congenic B6.129 mice. For each STR marker (colored box), name and position 
on Chr 2 are indicated on the left. Data show representative mice of at least three animals analyzed per group.
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mapped reads [FPKM], respectively, P = 0.73) or SIRP pro-
tein levels in mice with different Prnp-Sirpa haplotypes (Fig. 6 D). 
These results excluded any influence of Prnp or Sirpa alleles on 
the expression of each other.
In congenic B6.129 mice with different combinations of 
Prnp and Sirpa alleles (WT and ZrchI, B6 and 129, respectively), 
hyperphagocytosis segregated with Sirpa129/129 irrespectively of 
the Prnp status (Fig. 5, D and E). We compared phagocytosis by 
BMDMs isolated from congenic C.129-PrnpZrchI/ZrchI mice with 
different combinations of Prnp and Sirpa alleles (Fig. 7, A–C). 
In line with our findings with congenic B6.129 mice, a higher 
phagocytosis rate correlated with Sirpa129/129 independently of 
the Prnp alleles (Fig. 7, D and E). Together, these results exclude 
a role for PrPC and support Sirpa polymorphisms as a major 
regulator of phagocytosis in mouse strains carrying either WT 
or deleted Prnp alleles.
DISCUSSION
In the 1990s the Prnp gene became an extremely popular 
target among mouse geneticists and rapidly advanced to one 
of the most frequently inactivated elements of the mouse 
genome. As a result, we have indeed identified at least seven 
published mouse lines derived from independent gene- 
targeting events, all of which were analyzed in the present 
study. Remarkably, we discovered that all of these lines suffer 
from the same set of confounders when kept as congenic: 
a 129-derived genomic region sporting functionally impact-
ful polymorphisms.
The alleged control of phagocytosis of apoptotic cells by 
Prnp was critically questioned when we found that, in con-
trast to congenic B6.129- or C.129-PrnpZrchI/ZrchI and B6.129-
PrnpNgsk/Ngsk mice, co-isogenic 129-PrnpEdbg/Edbg mice did not 
display a hyperphagocytic phenotype. Moreover, microsatel-
lite-assisted breeding of B6129-PrnpZrchI/ZrchI mice revealed 
the existence of a 129-derived Chr 2 segment which, when 
homozygous, correlated with a higher rate of phagocytosis 
independent of Prnp. These data suggested that Prnp does not 
impact phagocytosis and that such conclusions in previous 
studies resulted from unrecognized polymorphic flanking 
genes (de Almeida et al., 2005). Detailed genomic, transcrip-
tomic, and functional analysis of candidate genes in the intro-
gressed 129-derived region in B6.129-PrnpZrchI/ZrchI mice 
supported a focus on the well-characterized inhibitor of 
phagocytosis Sirpa, whose polymorphisms alter this pheno-
type (Takenaka et al., 2007; Legrand et al., 2011; Strowig 
et al., 2011). Indeed, Sirpa129, rather than Prnp, segregated 
with increased phagocytosis.
B6.129-PrnpZrchI/ZrchI and B6.129-Prnpwt/wt macrophages 
displayed sequence variations, or differential expression, of 
several other genes in addition to Sirpa. In particular, Mertk 
(Scott et al., 2001), Tyro3 (Seitz et al., 2007), and Thbs1 (Gao 
et al., 1996), which participate in phagocytosis and are linked 
to Prnp, were polymorphic between the two strains. However, 
the genetic and functional considerations detailed above sug-
gested that they were unlikely candidates.
In our study, we have used mouse genetics to investigate 
the role of PrPC and its polymorphic flanking genes in modu-
lating phagocytosis of apoptotic cells. Compared with other 
experimental approaches, including gene silencing and over-
expression of exogenously introduced genes, formal genetics 
has the advantage of assessing the differential impact of physi-
ological versus absent expression of the gene under scrutiny. 
Moreover, silencing or overexpressing Sirpa, or other modu-
lators of phagocytosis, could alter the delicate balance between 
pro- and antiphagocytic signals (Hochreiter-Hufford and 
Ravichandran, 2013) and impact phagocytosis independently 
of whether this modulator is responsible for the difference 
between Prnp/ and Prnp+/+ macrophages.
Enzymatic removal of PrPC from macrophage surface 
through phosphoinositol phospholipase C was reported to re-
sult in an increased phagocytosis of apoptotic cells, seemingly 
confirming the role of PrPC in this process (de Almeida et al., 
2005). However, this treatment generically affects all glyco-
sylphosphatidylinositol-anchored proteins, many of which are 
involved in the control of phagocytosis (Dorahy et al., 1996; 
Cebecauer et al., 1998; Oliferenko et al., 1999; Kellner-Weibel 
et al., 2000; Peyron et al., 2000; Chimini, 2001; de Almeida and 
Linden, 2005). Therefore, it is questionable whether this effect 
is directly mediated by loss of surface PrPC.
Our study focused on the presumed role of PrPC in 
phagocytosis of apoptotic cells. Phagocytosis of zymosan par-
ticles and latex beads were also reported to be influenced by 
Prnp using primary macrophages or immortalized cell lines 
derived from Prnp/ and Prnp+/+ mice (de Almeida et al., 
2005; Nitta et al., 2009; Uraki et al., 2010). Our results raise 
the question of whether Sirpa polymorphisms may affect the 
responses to zymosan or phagocytosis of latex beads as well.
The co-segregation of Sirpa129 with Prnp in all the 
Prnp/ lines examined has implications beyond the control 
of phagocytosis. Because the Sirpa sequence of most mouse 
strains used for backcrossing of Prnp/ mice (B6, BALB/c, 
and FVB) differs from 129 mice (Sano et al., 1999; Takenaka 
et al., 2007), Sirpa is a potential confounder in most studies of 
Prnp/ mice. Importantly, the expression pattern of Sirpa 
mirrors that of Prnp and includes myeloid cells, neurons, and 
pancreatic  cells (Linden et al., 2008; Matozaki et al., 2009). 
Finally, PrPC-deficient mice share numerous subtle pheno-
types with Sirpa-ablated mice, including neuroimmunologi-
cal (Tomizawa et al., 2007; Tsutsui et al., 2008), behavioral 
(Nico et al., 2005; Ohnishi et al., 2010; Gadotti et al., 2012), 
and metabolic phenotypes (Kobayashi et al., 2008; Strom 
et al., 2011). These observations suggest that additional pheno-
types attributed to Prnp may actually reflect the effects of 
Sirpa polymorphisms.
Based on studies with Prnp/ mice, PrPC has been re-
cently reported to either induce or inhibit autophagy (Oh 
et al., 2008, 2012; Korom et al., 2013) and to be indispensable 
or dispensable to mediate A toxicity (Laurén et al., 2009; 
Balducci et al., 2010; Calella et al., 2010; Gimbel et al., 2010; 
Kessels et al., 2010; Cissé et al., 2011; Larson et al., 2012; Um 
et al., 2012). At least some of these controversies could reflect 
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found that the tga20 colony was contaminated with multiple 
combinations of Sirpa alleles early after its establishment. 
Hence the rescue of Prnp deficiency through a tga20 allele 
does not necessarily prove that the observed changes in pheno-
type are PrPC dependent.
It has been long suspected that genes flanking targeted 
loci may confound the interpretation of KO experiments 
(Smithies and Maeda, 1995; Gerlai, 1996). Recommendations 
the effect of polymorphic Prnp-flanking genes, and these 
findings merit critical reconsideration in light of our data.
The risk of flanking-gene problems can be reduced by 
reversing the phenotype of gene-targeted mice through trans-
genetic restoration of gene expression (Wolfer et al., 2002). 
With Prnp, this was often done by using PrPC-overexpressing 
tga20 mice, which were generated from PrnpZrchI/ZrchI mice and 
subsequently distributed to many laboratories. However, we 
Figure . Sirpa allelotype does not influence pM abundance or PrPC and SIRP expression. (A) Peritoneal lavages were gated for nucleated 
cells (left), and the percentage of F4/80+ cells was assessed (middle panel, right peak). (right) Overlay of histograms of F4/80 (dark blue), isotype antibody 
(light blue), and unstained peritoneal cells (gray) confirming the specificity of the staining. (B) Percentage of F4/80+ macrophages in peritoneal lavage 
cells of experimental mice. The dotted lines delineate individual experiments in which groups of mice (n = 3–10 for each haplotype) were analyzed. Error 
bars indicate SD. (C) PrPC ELISA analysis of pM lysates showed no difference (n.s.) in PrPC levels between B6.129-Prnpwt/wt mice with different Sirpa  
allelotypes. Two-tailed unpaired Student’s t test: P = 0.241; n = 3–4 for each haplotype. n.d., not detectable. (D) Unchanged expression of the SIRP  
cytoplasmic tail (CT) in cultured pM lysates as quantified to actin levels. SHPS-1 KO macrophage lysates lacking the cytosolic tail of SIRP were used  
as negative control. One-way ANOVA: n.s., not significant; P = 0.27; n = 3–4 for each haplotype. Horizontal bars indicate mean.
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Figure . Phagocytic activity level is associated with Sirpa9/9 allelotype but not with Prnp gene dosage also in C.9 congenic 
mice. (A) Breeding scheme to generate recombinant congenic C.129 mice with different combinations of Prnp (WT and ZrchI) and Sirpa (C and 
129) alleles. C.129-Prnpwt/ZrchI mice (F1) were intercrossed, and the occurrence of meiotic recombination between Prnp and Sirpa was assessed in 
the F2 offspring. 243 F2 mice with different combinations of Prnp genotypes and Sirpa allelotypes were obtained. Four mice (red frames) were 
found to carry a recombinant haplotype, and selected ones were bred to generate C.129-PrnpZrchI/ZrchI and C.129-Prnpwt/wt mice homozygous for 
SirpaC or Sirpa129 alleles. (B) RFLP analysis used to discriminate Sirpa129 from SirpaC alleles. C.129-Prnpwt/wt (first, third, and fifth lanes) and  
C.129-PrnpZrchI/ZrchI (second, fourth, and sixth lanes) mice with different combinations of Sirpa129 and SirpaC alleles. Controls are reference DNA. All 
animals entering the study were analyzed. (C) Protein sequence alignment of mouse SIRP Ig-like variable domain (IgV) illustrates recombinant 
congenic C.129 mice with different combinations of Prnp and Sirpa129 versus SirpaC (gray border). Blue boxes are SIRP protein reference se-
quences for the B6, 129/Sv, and C strains (yellow: polymorphisms). For each group one mouse was analyzed. (D) Sirpa129/129 allelotype, but not the 
absence of Prnp, was associated with hyperphagocytosis of BMDMs in congenic C.129 mice. Data are from three independent experiments (blue, 
black, and gray). Mean phagocytosis rates of C.129 PrnpZrchI/ZrchI SirpaB6/B6 were set as 100%. One-way ANOVA, Bonferroni’s multiple comparison 
post-test: #, P = 0.075; ****, P < 0.0001. Error bars indicate SD. (E) STR analysis documents the result of trans-allelic meiotic recombination be-
tween Prnp and Sirpa. Blue dashed line indicates the location of Prnp and Sirpa. For each STR marker (colored box), name and position on Chr 2 
are indicated on the left. Data show representative mice of at least three animals analyzed per group.
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Phagocytosis assay with BMDMs. On day 0, femurs were collected from 
age- and gender-matched adult mice and flushed with RPMI1640 medium 
(Gibco) containing 10% FBS (Gibco), 1% GlutaMAX (Gibco), and antibiot-
ics. BM cells were plated into 6-well plates at 2 × 106/well in 3 ml of culture 
medium containing 10 ng/ml of macrophage colony stimulation factor (In-
vitrogen) and cultured overnight at 37°C. On day 1, cells were transferred to 
new 6-well plates to remove loosely adherent stroma-like cells. On day 6, 
cells were harvested, adjusted to 5 × 105 cells in 500 µl, and plated into 24-
well plates. Apoptotic thymocytes (see above) were suspended at 106/ml in 
PBS and labeled with 20 ng/ml of the pH-sensitive dye pHrodo red, SE 
(Invitrogen) for 30 min at room temperature and washed, and 500 µl of cell 
suspension was added to BMDM culture for 1 h at 37°C. After washing, 
BMDMs were harvested with Accutase (Invitrogen) and gentle scraping and 
stained with FITC-labeled anti-CD11b or isotype control antibody (BD), 
and rate of phagocytosis was analyzed by flow cytometry as the percentage of 
pHrodo positivity among CD11b+ cells. At least 10,000 events were acquired 
in the living gate.
Genome-wide and Chr 2 short tandem repeat (STR) analysis.  
Genome-wide STR analysis was performed as previously described (Bremer 
et al., 2010). In brief, purified genomic DNA (gDNA) was amplified using 
multiplex PCR with fluorescently labeled primers (FAM, NED, and VIC; 
Applied Biosystems), diluted, denatured, and subjected to capillary electro-
phoresis on a 3130xl Genetic Analyzer (Applied Biosystems). Various mouse 
strains were used for calibration. Peak detection, binning, and allele calling 
were performed using the GeneMapper software (Applied Biosystems) in 
combination with in-house–developed software.
High-resolution STR genotyping on Chr 2. Novel microsatellite mark-
ers were generated as previously described (Ivakine et al., 2006; primer se-
quences in Table S4). DNA was amplified for 35 cycles: 30 s at 94°C, 30 s at 
55°C, and 1 min at 72°C using Multiplex Master Mix (QIAGEN). The PCR 
product was diluted 1/20, and 1 µl mixed with a 10-µl mixture containing 
formamide and a 500LIZ size standard. Samples were resolved on the 3730xl 
DNA Analyzer (Applied Biosystems). Alleles were sized, in comparison with 
standards, by viewing electropherograms in GeneMapper.
Library preparation for RNA sequencing. Total RNA was isolated from 
cultured pMs using the RNeasy mini kit (QIAGEN), snap frozen, and kept at 
80°C until further analysis. RNA quality was determined with Qubit (1.0) 
Fluorometer (Life Technologies) and Bioanalyzer 2100 (Agilent Technologies). 
Only samples with a 260 nm/280 nm ratio between 1.8 and 2.1 and a 28S/18S 
ratio between 1.5 and 2 were further processed. The TruSeq RNA Sample Prep 
kit v2 (Illumina) was used in the succeeding steps. In brief, total RNA samples 
(1 µg) were poly A enriched and reverse transcribed into double-stranded 
cDNA. TruSeq adapters were ligated to double-stranded cDNA. Fragments 
containing TruSeq adapters on both ends were selectively enriched with PCR. 
Quality and quantity of enriched libraries were validated using Qubit (1.0) 
Fluorometer and Caliper GX LabChip GX (Caliper Life Sciences). The pro-
duct is a smear with a mean fragment size of 260 bp. Libraries were nor-
malized to 10 nM in Tris-Cl 10 mM, pH 8.5, with 0.1% (vol/vol) Tween 20.
Cluster generation and RNA sequencing. TruSeq PE Cluster kit 
v3-cBot-HS (Illumina) was used for cluster generation using 2 pM of pooled 
normalized libraries on the cBOT. Sequencing was performed on Illumina 
HiSeq 2000 paired-end at 2 × 101 bp using the TruSeq SBS kit v3-HS (Illumina). 
Sequences have been deposited in NCBI Sequence Read Archive under SRA 
identifier no. SRP029761.
RNA sequencing data analysis. Reads were quality-checked with 
FastQC. Low-quality ends were clipped (3 bases from the start, 10 bases from 
the end). Trimmed reads were aligned to the reference genome and transcrip-
tome (FASTA and GIFF files, respectively, downloaded from the UCSC 
mm10 database) with TopHat version 2.0.6. TopHat was run with the follow-
ing options: mate inner distance set to 30, the corresponding SD to 100, and 
for breeding schemes and genetic quality control to avoid this 
problem were formulated (Wolfer et al., 2002; Ridgway et al., 
2007; Crusio et al., 2009) but rarely implemented (Holmdahl 
and Malissen, 2012). Consequently, reports of flanking gene 
effects are anecdotal and rely on the demonstration that a 
KO mouse phenotype is lost upon crossing to other strains 
backgrounds and reduction in length of the 129-derived re-
gion flanking the targeted locus (Kanagawa et al., 2000; de 
Ledesma et al., 2006; Eisener-Dorman et al., 2010). Our find-
ings provide an alternative mechanism underlying prior spe-
cific claims in the prion field and strengthen the requirement 
for rigorous genetic, genomic, and functional analyses to sup-
port the assignment of specific phenotypes to targeted muta-
tions in mice.
MATERIALS AND METHODS
Mice. The following mice were analyzed: PrnpZrchI/ZrchI mice (Büeler et al., 1992) 
on a mixed B6129 background or backcrossed to B6 for >12 generations or to 
C for >17 generations and congenic WT B6 and C mice purchased from Harlan 
or Charles River or bred in house; PrnpNgsk/Ngsk mice (Sakaguchi et al., 1995) 
extensively backcrossed to B6; PrnpEdbg/Edbg mice on a pure 129/Ola back-
ground (Manson et al., 1994) and co-isogenic WT 129/Ola mice; PrnpZrchII/ZrchII 
mice (Rossi et al., 2001) on a mixed B6129 background; PrnpGFP/GFP mice 
(Heikenwalder et al., 2008) backcrossed to B6 for 10 generations; tga20 mice 
(Fischer et al., 1996) on a mixed B6129 PrnpZrchI/ZrchI background; and SHPS-1 
(Inagaki et al., 2000) backcrossed to B6 for >5 generations. Genotype of mice 
was verified as indicated in the original description of each line (Table 1). To 
introduce SirpaB6 into B6129-PrnpZrchI/ZrchI mice, B6129-PrnpZrchI/ZrchI SirpaB6/B6 
tga20tg/tg mice were crossed with B6129-PrnpZrchI/ZrchI Sirpa129/129 mice (Fig. 4 A). 
To generate congenic B6.129-PrnpZrchI/ZrchI and Prnpwt/wt mice with all possible 
combinations of SirpaB6 and Sirpa129 alleles, B6.129-Prnpwt/ZrchI SirpaB6/129 mice 
were intercrossed, and recombination events between Prnp and Sirpa loci were 
identified by Prnp genotyping and RFLP analysis of Sirpa exon 2 in the offspring 
(Fig. 5, A and B). Mice with a recombinant haplotype (referred to as obligate 
carriers) were further crossed. The same approach was followed to generate 
congenic C.129-PrnpZrchI/ZrchI and Prnpwt/wt mice with all possible combina-
tions of SirpaC and Sirpa129 alleles (Fig. 7, A and B). All animal experiments were 
performed in compliance with the Swiss Animal Protection Law, under the 
approval of the Veterinary office of the Canton Zurich.
Allele discrimination analysis. To distinguish strain-specific alleles, 
PCR-RFLP analysis (Sirpa, Tyro3, and Thbs1) or sequencing (Mertk) were 
performed using primers and restriction enzymes as detailed in Table S4.
Phagocytosis assay with pMs. On day 0, peritoneal cells were collected 
from age- and gender-matched adult mice according to standard methods 
(Fortier and Falk, 2001), resuspended to 2.2 × 106 in 5 ml DMEM (Gibco) 
with 10% FBS (Gibco), 1% GlutaMAX (Gibco), and antibiotics, plated in 
one-well slide chambers (Falcon; BD), and incubated at 37°C. After 2 h, 
nonadhering cells were removed and remaining cells (referred to as cultured 
pMs) were kept overnight in culture. On day 1, thymocytes were harvested 
from 3–8-wk-old mice of the same background as the genotypes under in-
vestigation, incubated for 3 h at 37°C in the presence of 1 µM dexamethasone 
to induce apoptosis, washed, and added to the cultured pMs at different ra-
tios for 1 h. For each experimental group, technical replicates (at least dupli-
cates) were performed. Cells were washed, fixed with formalin, and stained 
with May-Grünwald-Giemsa. Slides were randomized and scanned with 
NanoZoomer (Hamamatsu Photonics), random fields (50 fields/slide) were 
generated, and phagocytosis rate was assessed using in-house–developed soft-
ware. The same operator blinded to experimental groups validated all soft-
ware-analyzed slides. For each technical replicate, >800 cells were evaluated 
(indicated as a dot in the graphs). Phagocytosis rate was defined as the per-
centage of macrophages having at least one apoptotic body.
 of 4 SIRP, not PrPC, controls phagocytosis | Nuvolone et al.
Aquino Fournier for RNA sequencing, D. Zimmermann for DNA sequencing; A. Wong 
for assistance with fine mapping; M. Heikenwaelder, T. Suter, R. Linden, H. Takizawa, Y. 
Saito, P. Pelczar, S. Hornemann, M. Hermann, S. Sorce, A.M. Callela, and S. Lesne for 
critical discussions; M. Bieri and N. Wey for software development; and Y. Fuhrer, M. 
Delic, P. Schwarz, R. Moos, L. Varrica, C. Tostado, and K. Schreiber for excellent 
technical help.
This work was supported by grants from Collegio Ghislieri, Pavia, Italy (to M. 
Nuvolone); the Swiss National Science Foundation (SNF; to V. Kana); the Canadian 
Institutes of Health Research (CIHR; #64216), Genome Canada, and the Juvenile 
Diabetes Research Foundation (#17-2011-520; to J.S. Danska); and the European 
Union (LUPAS, PRIORITY), the SNF, the Clinical Research Focus Program of the 
University of Zurich, the Foundation Alliance BioSecure, and the Novartis Research 
Foundation and an Advanced Grant of the European Research Council (to A. Aguzzi).
The authors have no conflicting financial interests.
Submitted: 19 June 2013
Accepted: 24 September 2013
REFERENCES
Aguzzi, A., and A.M. Calella. 2009. Prions: protein aggregation and infec-
tious diseases. Physiol. Rev. 89:1105–1152. http://dx.doi.org/10.1152/ 
physrev.00006.2009
Balducci, C., M. Beeg, M. Stravalaci, A. Bastone, A. Sclip, E. Biasini, L. Tapella, 
L. Colombo, C. Manzoni, T. Borsello, et al. 2010. Synthetic amyloid-beta 
oligomers impair long-term memory independently of cellular prion 
protein. Proc. Natl. Acad. Sci. USA. 107:2295–2300. http://dx.doi.org/ 
10.1073/pnas.0911829107
Barclay, A.N., and M.H. Brown. 2006. The SIRP family of receptors and 
immune regulation. Nat. Rev. Immunol. 6:457–464. http://dx.doi.org/10 
.1038/nri1859
Bremer, J., F. Baumann, C. Tiberi, C. Wessig, H. Fischer, P. Schwarz, A.D. 
Steele, K.V. Toyka, K.A. Nave, J. Weis, and A. Aguzzi. 2010. Axonal prion 
protein is required for peripheral myelin maintenance. Nat. Neurosci. 13: 
310–318. http://dx.doi.org/10.1038/nn.2483
Büeler, H.R., M. Fischer, Y. Lang, H. Bluethmann, H.P. Lipp, S.J. DeArmond, 
S.B. Prusiner, M. Aguet, and C. Weissmann. 1992. Normal development 
and behaviour of mice lacking the neuronal cell-surface PrP protein. 
Nature. 356:577–582. http://dx.doi.org/10.1038/356577a0
Calella, A.M., M. Farinelli, M. Nuvolone, O. Mirante, R. Moos, J. Falsig, I.M. 
Mansuy, and A. Aguzzi. 2010. Prion protein and Abeta-related synaptic 
toxicity impairment. EMBO Mol Med. 2:306–314. http://dx.doi.org/ 
10.1002/emmm.201000082
Cebecauer, M., J. Cerný, and V. Horejsí. 1998. Incorporation of leucocyte 
GPI-anchored proteins and protein tyrosine kinases into lipid-rich mem-
brane domains of COS-7 cells. Biochem. Biophys. Res. Commun. 243:706–
710. http://dx.doi.org/10.1006/bbrc.1998.8149
Chao, M.P., I.L. Weissman, and R. Majeti. 2012. The CD47-SIRP pathway in 
cancer immune evasion and potential therapeutic implications. Curr. Opin. 
Immunol. 24:225–232. http://dx.doi.org/10.1016/j.coi.2012.01.010
Chimini, G. 2001. Engulfing by lipids: a matter of taste? Cell Death Differ. 
8:545–548. http://dx.doi.org/10.1038/sj.cdd.4400833
Cissé, M., P.E. Sanchez, D.H. Kim, K. Ho, G.Q. Yu, and L. Mucke. 2011. 
Ablation of cellular prion protein does not ameliorate abnormal neu-
ral network activity or cognitive dysfunction in the J20 line of human 
amyloid precursor protein transgenic mice. J. Neurosci. 31:10427–10431. 
http://dx.doi.org/10.1523/JNEUROSCI.1459-11.2011
Collinge, J., M.A. Whittington, K.C. Sidle, C.J. Smith, M.S. Palmer, A.R. Clarke, 
and J.G. Jefferys. 1994. Prion protein is necessary for normal synaptic 
function. Nature. 370:295–297. http://dx.doi.org/10.1038/370295a0
Crusio, W.E., D. Goldowitz, A. Holmes, and D. Wolfer. 2009. Standards for the 
publication of mouse mutant studies. Genes Brain Behav. 8:1–4. http://
dx.doi.org/10.1111/j.1601-183X.2008.00438.x
de Almeida, C.J., and R. Linden. 2005. Phagocytosis of apoptotic cells: a 
matter of balance. Cell. Mol. Life Sci. 62:1532–1546. http://dx.doi.org/ 
10.1007/s00018-005-4511-y
de Almeida, C.J., L.B. Chiarini, J.P. da Silva, P.M. E Silva, M.A. Martins, and 
R. Linden. 2005. The cellular prion protein modulates phagocytosis and 
inflammatory response. J. Leukoc. Biol. 77:238–246. http://dx.doi.org/10 
.1189/jlb.1103531
maximum 10 multi-hits were allowed in the alignment. Reads that did not 
align at the first attempt were split into 25-base-long sections on which a 
second attempt of alignment was performed. In B6.129-PrnpZrchI/ZrchI pMs, 
all reads mapping to Prnp between BstEII and EcoRI restriction sites in exon 
3 and in the 3 UTR, respectively, possibly representing a fused mRNA con-
taining neo and residual Prnp, reported in the brain of these mice (Büeler et al., 
1992), were excluded from the analysis. Polymorphisms were detected using 
GATK version 2.1.8 using the following options: baq Gap open penalty 
(whole-genome analysis) set to 30; minimum consensus coverage to geno-
type indels set to 8 (default: 5); minimum base quality score and minimum 
variants phred score set to 15. Variants were annotated using snpEFF version 
3.0, and distribution of the reads across genomic isoform expression was 
quantified using RSEM (Li and Dewey, 2011). Cufflinks version 2.0.2 and 
differentially expressed genes listed with its utility Cuffdiff using default op-
tions were used.
All remaining data and statistical analyses, formatting, and picture gener-
ating were produced via in-house R-scripts (R version 2.15.2). The SIFT algo-
rithm with default settings was used to predict the impact of a nonsynonymous 
SNP in Mertk (Kumar et al., 2009).
Sirpa open reading frame sequencing. Cultured pM cDNA and 
gDNA were used to PCR amplify and sequence coding and untranslated re-
gions of mouse Sirpa as previously described (Takenaka et al., 2007). Primers 
(Microsynth) are listed in Table S4. For PrnpRkn/Rkn mice, sequencing was per-
formed on gDNA obtained from Institute of Physical and Chemical Re-
search, Japan, and from cDNA isolated from PrnpRkn/Rkn–derived hippocampal 
like cells (HpL3-4; Kuwahara et al., 1999). For PrnpRcm0/Rcm0 mice, only gDNA 
from one single mouse was available, and sequencing was performed only on 
the highly polymorphic exon 2 of Sirpa.
Western blotting. Western blotting on pM cell lysates was performed ac-
cording to standard methods using polyclonal anti-Sirpa cytoplasmic tail 
(CT) antibody (IMGENEX).
PrPC-ELISA. PrPC was quantified in cultured pM lysates by sandwich ELISA 
as described previously using POM1 and POM2 antibodies (Polymenidou 
et al., 2008).
Flow cytometry analysis. Freshly isolated peritoneal cells were incubated 
with FITC-labeled anti-F4/80 or isotype control antibody (BD). Thymocyte 
apoptosis was assessed using the FITC Annexin V Apoptosis Detection kit II 
(BD). Flow cytometry was performed using a FACSCalibur or a FACSCanto 
(BD), and data were acquired with CellQuest Pro or FACSDiva software, re-
spectively, and analyzed with FlowJo software (Tree Star).
Statistical analysis. Comparisons of phagocytic activity of macrophages of 
different genotypes were performed using one-way ANOVA and Bonferroni’s 
multiple comparison post-test ( level 0.05) or two-tailed unpaired Student’s 
t test using Prism software (GraphPad Software). The statistical test, p-values, 
and the n for each statistical analysis are indicated in each of the correspond-
ing figure legends.
Online supplemental material. Figs. S1 and S2 illustrate the genomic 
characterization of experimental mice. Tables S1 and S2, included as separate 
PDF files, list relevant genes identified by RNA sequencing. Table S3 lists 
allelotypes of experimental mice. Table S4 lists primer sequences and restric-
tion enzymes used for genetic analysis. Online supplemental material is avail-
able at http://www.jem.org/cgi/content/full/jem.20131274/DC1.
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